Bank of Montreal
SAGE

Bank of Montreal’s Sage Therapeutics SAGE Stock Holding History

Bank of Montreal’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-20,000
Closed -$882K – 4909
2020
Q2 		$882K Buy
+20,000
New +$726K ﹤0.01% 1990

Other funds holding SAGE

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bank of Montreal's SAGE Position: Q3 2025 in Review

Bank of Montreal sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 15,467 shares — an estimated $141K sold.

Bank of Montreal first reported a position in SAGE in Q2 2015 and held it in 30 quarters. The position peaked at $8.92M in Q3 2021. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

  • Bank of Montreal reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Bank of Montreal sold 15,467 Sage Therapeutics shares in Q3 2025, an estimated $141K.
  • Bank of Montreal first reported a position in Sage Therapeutics in Q2 2015 and held it in 30 quarters.
  • Bank of Montreal's Sage Therapeutics position peaked at $8.92M in Q3 2021.
  • 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on Bank of Montreal's 13F filing for Q3 2025, filed 13 Nov 2025.